1. [P4–576]: FIRST‐IN‐HUMAN PHASE I RESULTS SHOW SAFETY, TOLERABILITY AND BRAIN PENETRANCE OF ORY‐2001, AN EPIGENETIC DRUG TARGETING LSD1 AND MAO‐B. (1st July 2017) Authors: Maes, Tamara; Molinero, Cesar; Antonijoan, Rosa M.; Ferrero‐Cafiero, Juan Manuel; Martínez‐Colomer, Joan; Mascaro, Cristina; Arevalo, Maria Isabel Journal: Alzheimer's & dementia Issue: Volume 13:Supplement 7S(2017)Part 32 Page Start: P1573 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P4‐404: Ory‐2001: An Epigenetic Drug for the Treatment of Cognition Defects in Alzheimer'S Disease and Other Neurodegenerative Disorders. (1st July 2016) Authors: Maes, Tamara; Mascaró, Cristina; Rotllant, David; Cavalcanti, Fernando; Carceller, Elena; Ortega, Alberto; Molinero, Cesar; Buesa, Carlos Journal: Alzheimer's & dementia Issue: Volume 12:Supplement 7S(2014)Part 24 Page Start: P1192 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗